Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income attributable to common shareholders		$ 11,644,879	$ 2,657,245
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments		(39,703)	17,036
Other-than-temporary impairments		0	0
Realized investment gains, net		(1,113,698)	(534,242)
Change in fair value of equity securities	[1]	(14,787,631)	(4,129,236)
Amortization of cost of insurance acquired		193,977	201,516
Depreciation		323,406	275,143
Net income attributable to noncontrolling interest		153,733	29,500
Charges for mortality and administration of universal life and annuity products		(1,619,743)	(1,650,201)
Interest credited to account balances		1,029,303	883,563
Change in accrued investment income		232,788	(357,576)
Change in reinsurance receivables		(61,726)	35,546
Change in policy liabilities and accruals		(772,518)	(6,961)
Change in income taxes receivable (payable)		612,616	12,974
Change in other assets and liabilities, net		3,839,857	5,894,257
Net cash provided by (used in) operating activities		(364,460)	3,328,564
Proceeds from investments sold and matured:
Fixed maturities available for sale		2,023,974	14,515
Equity securities		33,075	103,298
Mortgage loans		1,945,760	2,009,715
Real estate		3,045,226	7,941,649
Notes receivable		1,537,984	563,926
Policy loans		410,831	366,847
Short-term investments		0	850,000
Total proceeds from investments sold and matured		8,996,850	11,849,950
Cost of investments acquired:
Fixed maturities available for sale		0	(4,971,517)
Equity securities		(46,509)	(7,957,471)
Mortgage loans		(3,575,500)	0
Real estate		(1,174,688)	(6,006,130)
Notes receivable		(4,416,008)	0
Policy loans		(324,587)	(405,337)
Short-term investments		0	(850,000)
Total cost of investments acquired		(9,537,292)	(20,190,455)
Net cash used in investing activities		(540,442)	(8,340,505)
Cash flows from financing activities:
Policyholder contract deposits		1,264,011	1,149,533
Policyholder contract withdrawals		(1,231,379)	(1,245,743)
Purchase of treasury stock		(212,387)	(600,240)
Issuance of stock		229,800	230,000
Noncontrolling contributions (distributions) of consolidated subsidiary		(245,750)	(146)
Net cash used in financing activities		(195,705)	(466,596)
Net decrease in cash and cash equivalents		(1,100,607)	(5,478,537)
Cash and cash equivalents at beginning of period		20,150,162	25,434,199
Cash and cash equivalents at end of year		$ 19,049,555	$ 19,955,662

[1] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 2.